Duke University
UEI TP7EK8DZV6N5 · NC · SAM.gov record ↗
$67.1M
FY2025 obligations
116
Contract awards
Sep 8, 2014
First action
Jun 30, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$61.9M
- Department Of Defense$2.6M
- Department Of The Interior$1.3M
- Department Of Veterans Affairs$761K
- National Aeronautics And Space Administration$494K
- Environmental Protection Agency$103K
- Department Of Homeland Security$0
- Department Of Transportation$0
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 80NSSC25PB512 ↗ | PERFORM ON LIGHTNING ADVISORY PANEL | National Aeronautics And Space Administration | 611310 | $35K | Jul 21, 2025 | Jul 21, 2026 |
| 75N94019F00126 ↗ | NICHD: SERVICES: TO PROVIDE A PLATFORM FOR THE INCLUSION OF PATIENTS WITH DOWN SYNDROME INTO THE PHARMACOLOGY-BASED CLINICAL TRIALS. THE GOALS ARE TO RECRUIT THIS PATIENT POPULATION INTO THE PEDIATRIC TRIALS NETWORK AND TO DEVELOP A TRAINING PROGRAM | National Institutes Of Health | 541715 | $0 | Sep 11, 2019 | Jul 30, 2026 |
| 75N94021F00002 ↗ | NICHD: R&D: DEFINING THE SAFETY AND EFFICACY OF POSTERIOR TIBIAL NERVE STIMULATION IN CHILDREN (POSITRON-C): NON-SEVERABLE | National Institutes Of Health | 541715 | $-1.2M | Sep 12, 2021 | Jul 30, 2026 |
| 75N90025P00636 ↗ | RAW DATA COLLECTION: PROTEIN ID BY ORBITRAP ASTRAL WITH EVOSEP ONE UPLC WITH 40MIN GRADIENT DUKE UNIV MED CTR:1109092 [25-007545] | National Institutes Of Health | 611310 | $27K | Aug 12, 2025 | Aug 11, 2026 |
| 36C24625P1481 ↗ | LABORATORY SERVICE WITH DUKE UNIVERSITY AT DURHAM VAMC | Department Of Veterans Affairs | 541714 | $83K | Aug 21, 2025 | Aug 20, 2026 |
| 36C24625P1548 ↗ | BRPC LAB SERVICES | Department Of Veterans Affairs | 541714 | $22K | Sep 11, 2025 | Sep 10, 2026 |
| 36C24623P1586 ↗ | BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY | Department Of Veterans Affairs | 541714 | $616K | Sep 12, 2023 | Sep 11, 2026 |
| 36C24E25C0008 ↗ | RNA EXTRACTION AND SEQUENCING | Department Of Veterans Affairs | 541720 | $293K | Sep 17, 2025 | Sep 16, 2026 |
| 75N94025F00002 ↗ | NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE | National Institutes Of Health | 541715 | $2.9M | Sep 19, 2025 | Sep 18, 2026 |
| 36C24625P1474 ↗ | NEUROIMAGING AND DATA ANALYTICS SERVICES | Department Of Veterans Affairs | 541714 | $22K | Sep 25, 2025 | Sep 24, 2026 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93019C00050 ↗ | THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST | National Institutes Of Health | 541715 | $9.0M | Sep 9, 2019 | Apr 30, 2027 |
| 75N93019C00054 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE | National Institutes Of Health | 541715 | $8.9M | Sep 15, 2019 | Dec 30, 2030 |
| 75N93024F00001 ↗ | EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) | National Institutes Of Health | 541715 | $8.2M | Sep 29, 2024 | Sep 28, 2031 |
| 75N93025C00006 ↗ | NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT | National Institutes Of Health | 541715 | $5.1M | Mar 29, 2025 | Mar 28, 2032 |
| 75N94025F00001 ↗ | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND | National Institutes Of Health | 541715 | $4.8M | Jun 3, 2025 | Jun 2, 2027 |
| 75R60220C00008 ↗ | DUKE - NATIONAL CORD BLOOD INVENTORY | Health Resources And Services Administration | 621991 | $4.4M | Jul 9, 2020 | Sep 2, 2035 |
| 75N93022C00053 ↗ | ADJUVANT COMPARISON AND CHARACTERIZATION | National Institutes Of Health | 541714 | $3.4M | Aug 31, 2022 | Apr 29, 2028 |
| 75N93024F00001 ↗ | FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA | National Institutes Of Health | 541715 | $3.4M | Aug 30, 2024 | Aug 26, 2028 |
| 75N93026C00005 ↗ | VIROLOGY QUALITY ASSURANCE (VQA) | National Institutes Of Health | 541715 | $3.4M | Jun 20, 2026 | Jun 19, 2027 |
| 75N93019C00015 ↗ | THIS CONTRACT WILL PROVIDE LABORATORIES PERFORMING VIROLOGIC TESTING FOR NIAID-SPONSORED CLINICAL TRIALS (LABS) WITH A COMPREHENSIVE QUALITY ASSESSMENT PROGRAM FOR VIROLOGIC ASSAYS FOR HIV AND OTHER VIRAL PATHOGENS INCLUDING PROFICIENCY TESTING PROGR | National Institutes Of Health | 541715 | $3.4M | Jun 20, 2019 | Jun 19, 2026 |
| 75N94025F00002 ↗ | NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE | National Institutes Of Health | 541715 | $2.9M | Sep 19, 2025 | Sep 18, 2026 |
| 75N93021C00010 ↗ | IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM | National Institutes Of Health | 541715 | $1.9M | Sep 29, 2021 | Sep 28, 2026 |
| 75N93025C00002 ↗ | VIROLOGY CORE LABORATORY | National Institutes Of Health | 541715 | $1.9M | Dec 14, 2024 | Dec 13, 2026 |
| 75N93024C00005 ↗ | PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7 | National Institutes Of Health | 541714 | $1.5M | Feb 29, 2024 | Feb 27, 2027 |
| 75N93024C00074 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE(MARCH 19, 2025)::EOI INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY | National Institutes Of Health | 541714 | $1.4M | Sep 29, 2024 | Sep 28, 2026 |
| 140D0422P0227 ↗ | NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATION AND MAINTENANCE SERVICES | Departmental Offices | 541690 | $1.3M | Sep 25, 2022 | Sep 28, 2026 |
| 75N93022F00001 ↗ | RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING | National Institutes Of Health | 541715 | $1.0M | Nov 30, 2021 | Nov 29, 2026 |
| 75N93019C00053 ↗ | 19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE. | National Institutes Of Health | 541714 | $764K | Aug 25, 2019 | Sep 14, 2028 |
| 75F40125C00053 ↗ | THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC | Food And Drug Administration | 541714 | $750K | Sep 7, 2025 | Mar 30, 2028 |
| 36C24623P1586 ↗ | BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY | Department Of Veterans Affairs | 541714 | $616K | Sep 12, 2023 | Sep 11, 2026 |
| N3560A26FB105 ↗ | SPRING 2026 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES | Department Of The Navy | 611310 | $546K | Feb 21, 2026 | Apr 21, 2026 |
| 75N93022F00001 ↗ | TASK AREA A: ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | National Institutes Of Health | 541715 | $388K | Jan 13, 2022 | Jan 12, 2027 |
| 80NSSC26P0252 ↗ | DECOMPRESSION SICKNESS TESTING - SAT | National Aeronautics And Space Administration | 621511 | $350K | Feb 16, 2026 | Feb 16, 2027 |
| N3560A25FB016 ↗ | SPRING 2025 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES | Department Of The Navy | 611310 | $309K | Feb 20, 2025 | Apr 27, 2025 |
| 36C24E25C0008 ↗ | RNA EXTRACTION AND SEQUENCING | Department Of Veterans Affairs | 541720 | $293K | Sep 17, 2025 | Sep 16, 2026 |
Subsidiaries under this parent
- Private Diagnostic Clinic, Pllc ($7.6M)